UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | -0.27 | -0.27 |
| Q1 2022 | 2022-05-05 | -0.39 | -0.39 |
| Q4 2021 | 2022-02-24 | -0.33 | -0.33 |
| Q3 2021 | 2021-11-08 | -0.47 | -0.47 |
| Q2 2021 | 2021-08-05 | -0.35 | -0.35 |
| Q1 2021 | 2021-05-07 | -0.31 | -0.31 |
| Q4 2020 | 2021-02-25 | -0.46 | -0.46 |
| Q3 2020 | 2020-11-05 | -0.14 | 0.00 |
| Q2 2020 | 2020-08-10 | -0.95 | -0.95 |
| 2016-05-31 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-05-23 | Initiated Coverage | HC Wainwright | Buy | $55.00 |
| 2016-05-06 | Initiated Coverage | Cowen and Company | Outperform | |
| 2016-04-04 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-03-31 | Reiterated Rating | Cantor Fitzgerald | Buy | $70.00 |
| 2016-03-30 | Initiated Coverage | Goldman Sachs | Neutral | $37.00 |
| 2016-03-30 | Initiated Coverage | Goldman Sachs Group Inc. | Neutral | $37.00 |
| 2016-02-26 | Reiterated Rating | Cantor Fitzgerald | Buy | $70.00 |
| 2016-02-24 | Downgrade | Jefferies Group | Buy to Hold | $37.00 |
| 2016-02-22 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-02-22 | Reiterated Rating | Canaccord Genuity | Buy | $85.00 |
| 2016-02-11 | Reiterated Rating | Jefferies | Buy | $37.00 |
| 2016-02-11 | Lower Price Target | Jefferies Group | Buy | $37.00 |
| 2016-02-02 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-01-31 | Reiterated Rating | Canaccord Genuity | Buy | $85.00 |
| 2016-01-25 | Reiterated Rating | Bank of America | Buy | $89.00 |
| 2016-01-25 | Reiterated Rating | Bank of America Corp. | Buy | $89.00 |
| 2016-01-22 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2015-12-11 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2015-12-11 | Reiterated Rating | Canaccord Genuity | Buy | $85.00 |
| 2015-11-18 | Lower Price Target | Jefferies Group | $79.00 to $77.00 | |
| 2015-11-17 | Reiterated Rating | Canaccord Genuity | Buy | $85.00 |
| 2015-10-18 | Reiterated Rating | Cowen and Company | Outperform | |
| 2015-10-12 | Reiterated Rating | Canaccord Genuity | Buy | $85.00 |
| 2015-10-02 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $88.00 |
| 2015-09-25 | Reiterated Rating | Cantor Fitzgerald | Buy | $85.00 |
| 2015-09-24 | Boost Price Target | Canaccord Genuity | Buy | $70.00 to $85.00 |
| 2015-08-14 | Initiated Coverage | Deutsche Bank | Buy | $90.00 |
| 2015-08-14 | Initiated Coverage | Deutsche Bank AG | Buy | $90.00 |
| 2015-08-07 | Reiterated Rating | Canaccord Genuity | Buy | $70.00 |
| 2015-08-07 | Boost Price Target | Jefferies Group | Buy | $66.00 to $79.00 |
| 2015-08-07 | Boost Price Target | Cantor Fitzgerald | Buy | $71.00 to $85.00 |
| 2015-07-16 | Reiterated Rating | Canaccord Genuity | Buy | $70.00 |
| 2015-06-22 | Downgrade | Maxim Group | Buy to Hold | |
| 2015-06-21 | Reiterated Rating | Cowen and Company | Outperform | |
| 2015-06-18 | Reiterated Rating | Canaccord Genuity | Buy | $70.00 |
| 2015-06-18 | Boost Price Target | Cantor Fitzgerald | Buy | $58.00 to $71.00 |
| 2015-04-24 | Initiated Coverage | Cowen and Company | Buy | $50.00 |
| 2015-04-23 | Initiated Coverage | Maxim Group | Buy | $50.00 |
| 2015-03-11 | Reiterated Rating | Jefferies Group | Buy | $45.00 to $56.00 |
| 2015-03-11 | Boost Price Target | Cantor Fitzgerald | Buy | $52.00 to $58.00 |
| 2015-02-02 | Initiated Coverage | Bank of America | Buy | $60.00 |
| 2015-01-29 | Reiterated Rating | Canaccord Genuity | Buy | $70.00 |
| 2015-01-14 | Reiterated Rating | Canaccord Genuity | Buy | $70.00 |
| 2014-12-23 | Boost Price Target | Jefferies Group | $45.00 | |
| 2014-12-22 | Boost Price Target | Cantor Fitzgerald | Buy | $26.00 to $52.00 |
| 2014-11-12 | Reiterated Rating | Cantor Fitzgerald | Buy | $20.00 to $26.00 |
| 2014-10-10 | Reiterated Rating | Canaccord Genuity | Buy | $26.00 to $30.00 |
| 2014-09-19 | Reiterated Rating | Canaccord Genuity | Buy | $21.00 to $26.00 |
| 2014-07-16 | Initiated Coverage | Cowen and Company | Outperform | |
| 2014-07-16 | Initiated Coverage | Cantor Fitzgerald | Buy | $20.00 |
| 2014-07-16 | Initiated Coverage | Canaccord Genuity | Buy | $21.00 |
| 2014-07-16 | Initiated Coverage | Jefferies Group | Buy | $17.00 |
| 2016-05-31 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-05-23 | Initiated Coverage | HC Wainwright | Buy | $55.00 |
| 2016-05-06 | Initiated Coverage | Cowen and Company | Outperform | |
| 2016-04-04 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-03-31 | Reiterated Rating | Cantor Fitzgerald | Buy | $70.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In RDUS 28 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 1.57M |
| BlackRock Institutional Trust Company, N.A. | 0.87M |
| TEACHERS ADVISORS INC | 0.53M |
| GOLDMAN SACHS GROUP INC | 0.50M |
| Apex Capital Management | 0.44M |
| Rock Creek Group, LP | 0.34M |
| PICTET ASSET MANAGEMENT LTD | 0.29M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.28M |
| Old Mutual Global Investors (UK) Ltd. | 0.13M |
| BlackRock Investment Management, LLC | 0.12M |
| VIRGINIA RETIREMENT SYSTEMS ET AL | 89800 |
| CHICAGO EQUITY PARTNERS LLC | 86730 |
| BOSTON ADVISORS LLC | 61012 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 54545 |
| CATAPULT CAPITAL MANAGEMENT LLC | 36000 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| BIOTECH GROWTH N V | 20.34% (6050913) | RDUS / |
| EVNIN LUKE | 19.60% (5831253) | CNAT / EPRS / EPZM / ETRM / KBIO / PCRX / PIP / RDUS / |
| GALAKATOS NICHOLAS | 12.40% (3689706) | NSTG / OPHT / PTLA / RDUS / |
| MPM BIOVENTURES III LLC | 12.40% (3689706) | EPRS / PIP / RDUS / |
| GADICKE ANSBERT | 7.20% (2141547) | ETRM / PETX / RDUS / |
| MPM BioVentures IV LLC | 7.20% (2141547) | RDUS / |
| BROOKSIDE CAPITAL MANAGEMENT LLC | 6.53% (1943241) | CNCE / DRNA / IDIX / NSPH / RDUS / |
| Muenchbach Martin | 4.68% (1393443) | RDUS / |
| Harvey Brian Nicholas Sr VP & CFO, Sec. & Treasurer | 0.26% (76189) | RDUS / |
| Lyttle Cecil Richard President and C.E.O. | 0.22% (66666) | RDUS / |
| O'Dea Louis Sr VP, Chief Medical Officer | 0.10% (29207) | AKCA / RDUS / |
| Ward Robert President & CEO | 0.08% (25000) | RDUS / |
| Graves Kurt | 0.08% (22694) | ACHN / RDUS / RTGN / |
| FLEMING JONATHAN | 0.05% (15324) | RDUS / XNCR / |
| Hoiland Jesper President and CEO | 0.04% (12900) | RDUS / |
| Snow David P. Chief Commercial Officer | 0.02% (6000) | RDUS / |
| Carmona Jose Chief Financial Officer | 0.01% (3000) | RDUS / |
| Hatzis-Schoch Brent Sr. VP, General Counsel | 0.01% (2278) | RDUS / |
UM